Year: 2021

First-in-Human Study Expected to be Initiated in the First Quarter of 2022 An Approved Test Would Lead to Identification of People Requiring Vaccine Boosters CHATHAM, N.J., Dec. 14, 2021 (GLOBE NEWSWIRE) —  Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application to initiate a first-in-human clinical study for TNX-2100 (SARS-CoV-2 epitope peptide mixtures for intradermal administration), a skin test to measure delayed-type hypersensitivity (DTH) to SARS-CoV-2 (CoV-2), the virus that causes COVID-19. DTH is a measure of T cell immunity. Tonix expects to initiate the clinical study in the first quarter of 2022. “When fully developed, our proposed skin...

Dr. Michal Okoniewski with the Clean Tech Inverter (CTI)Acceleware believes the CTI can economically decarbonize many industry verticals through electrification with immediate application in the clean energy transition.AKITA 34 at MarwayneAkita’s Rig 34 was used to drill the remaining two heating lateral sections and install the proprietary RF XL transmission lines at the commercial pilot test.CALGARY, Alberta, Dec. 14, 2021 (GLOBE NEWSWIRE) — Acceleware Ltd. (“Acceleware” or the “Company”) (TSXV: AXE), a Canadian clean-tech innovator of radio frequency (RF) heating technologies that enable the electrification of industrial heat and promise a dramatic reduction in greenhouse gas (GHG) emissions, today announced that the Company has finished its drilling and completions program for the commercial-scale...

Performance year-to-date represents a 71% increase in net income and 101% increase in total revenues over the same period in 2020Realized gain on investments was $4.2 million, offset by an unrealized loss on investments of $8.1 million, for net loss on investments of $3.9 million for the three months ended October 31, 2021As at October 31, 2021, Aberdeen’s shareholders’ equity was $46.6 million, or $0.34 per basic share. On a year-over-year basis, Aberdeen’s shareholders’ equity has increased 44%The Company continues to be well positioned as a result of investments in clean energy and zero-carbon technologies with core positions buoying the portfolio year to date with a $8.4M increase in fair value. The Company has tactically reduced positions in alternative sectorsTORONTO, Dec. 14, 2021 (GLOBE NEWSWIRE) —...

DUBLIN, Ireland, Dec. 14, 2021 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel”), an emerging leader in the green hydrogen sector, is pleased to announce the appointment of Theresa “Terry” Jester to the Company’s Board of Directors. Ms. Jester currently serves on the Boards of NEXT Energy Technologies, a developer of organic photovoltaic coatings used to transform windows into energy-producing assets, and Silicor Materials, a global leader in the production of solar silicon. She previously served as CEO of BIA Controls, a developer and installer of demand management, energy management and building automation software systems. With over forty years of experience in the solar and electronics manufacturing industries, Mr. Jester began her career at ARCO Solar in 1979 where she helped develop and commercialize...

CAMBRIDGE, Mass., Dec. 14, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing SINTAX™ medicines as a new modality of orally delivered treatments for inflammatory disease, today announced that the Company has been added to the NASDAQ Biotechnology Index® (Nasdaq: NBI), effective prior to market open on December 20, 2021. The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® (Nasdaq®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology. Companies in the NASDAQ Biotechnology Index must meet eligibility requirements, including minimum market...

IONiX Pro has now Sold Out of Home SmartWalls and Daymak purchases an additional 5,000,000 ACDC shares Vancouver B.C., Dec. 14, 2021 (GLOBE NEWSWIRE) — Extreme Vehicle Battery Technologies Corp. (the “Company” or “EV Battery Tech”) (CSE: ACDC) (OTCQB: CRYBF) and IONiX Pro Battery Technologies Corp. (“IONiX Pro”) are excited to announce that their partner, Daymak Inc. (“Daymak”), has submitted an order for 1,000 units of the IONiX Pro Home SmartWall (the “SmartWall”) and has purchased an additional 5,000,000 common shares in the Company. On September 28, 2021, the Company announced that IONiX Pro would be recommencing taking pre-orders for its flagship SmartWall, with an estimated price of 5,500 USD per unit. The Company stated that due to global supply shortages, particularly of battery cells and circuit boards, IONiX Pro would...

Oral presentation provides first look at new program, IMR-261, a novel, oral, clinic-ready nuclear factor erythroid 2-related factor 2 (Nrf2) activator SCD Townes mouse model demonstrates IMR-261 activation of Nrf2 increases HbF and F-cells, reduces VOCs and reduces markers of adhesion and hemolysis Beta-thalassemia mouse model shows IMR-261 increases hemoglobin and improves ineffective erythropoiesis BOSTON, Dec. 14, 2021 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat subjects suffering from rare inherited genetic disorders of hemoglobin and other serious diseases, today announced the presentation of data from its nuclear factor erythroid 2-related factor 2 (Nrf2) activator program, IMR-261, at the American Society...

Southern Glazer’s becomes first North American wine and spirits distributor to test electric delivery vehicles MIAMI and DALLAS, Dec. 14, 2021 (GLOBE NEWSWIRE) — Southern Glazer’s Wine & Spirits (Southern Glazer’s)—the world’s preeminent distributor of beverage alcohol—today announced it has signed a purchase order with Xos, Inc. (NASDAQ: XOS), a leading manufacturer of fully electric Class 5 to Class 8 commercial vehicles, for 10 Xos Class 7 refrigerated beverage trucks. This initial test of electric trucks will be used to inform future deployments of Xos electric vehicles into the Company’s national fleet. “We’re proud and excited to be the first North American wine and spirits distributor in the U.S. to incorporate electric vehicles into our fleet on this scale,” said Ron Flanary, Senior Vice President of Operations,...

PHILADELPHIA, Dec. 14, 2021 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today reported top-line data on biologic activity from the two lowest dose cohorts in the DesCAARTes™ Phase 1 clinical trial of DSG3-CAART for the treatment of patients with mucosal Pemphigus Vulgaris (mPV).    As of December 12, 2021, six patients, comprising the two lowest dose cohorts (20 million and 100 million DSG3-CAART cells administered without lymphodepletion) had completed three to six months of follow-up for evaluation of DSG3-CAART biologic activity. Patients enrolled had persistent mild to moderate disease severity prior to infusion despite receiving or having received systemic...

Retail industry veteran brings strong finance, information technology and merchandising experience DALLAS, Dec. 14, 2021 (GLOBE NEWSWIRE) — Tuesday Morning Corporation (NASDAQ: TUEM), a leading off-price retailer of home goods and décor, today announced that Marcelo Podesta, an information technology and merchandising industry leader, joined the company’s board of directors (the “Board”) as an independent director, effective December 13, 2021. “On behalf of the Board and the Tuesday Morning management team, I am pleased to welcome Marcelo Podesta to our Board,” said Sherry Smith, Chairperson of the Board of Tuesday Morning. “Marcelo’s deep experience and retail industry knowledge make him uniquely qualified to contribute to Tuesday Morning as we focus on driving long-term growth and shareholder value.” Mr. Podesta is a seasoned...